Please login to the form below

Not currently logged in

pain treatment

This page shows the latest pain treatment news and features for those working in and with pharma, biotech and healthcare.

The Final Frontier

The Final Frontier

Maybe. The Canadian Pain Society recently moved cannabinoid therapy up from a fourth-line treatment option to a third-line treatment option for neuropathic pain. ... They sent questionnaires to households asking about self-reported pain frequency,

Latest news

More from news
Approximately 2 fully matching, plus 98 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    One potential major product launch for 2019 will be novel pain drug tanezumab. ... These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December.

  • Mobile health and patient outcomes Mobile health and patient outcomes

    Putting the humanity back into patient care. Healthcare professionals, scientists and pharmaceutical companies’ understanding of the daily impact of disease and treatment on a person’s life are not always as ... In a recent study in rheumatoid

  • Deal Watch - May 2017 Deal Watch - May 2017

    its bupivacaine collagen implant for treatment of post-operative pain. ... 1, 050. Akebia (US). Otsuka (JP). Licence expansion selected countries. Vadadustat in phase 3 for treatment of anaemia.

  • Deal Watch February 2017 Deal Watch February 2017

    Cynosure's portfolio of more than 20 products covers areas such as non-invasive body contouring (including SculpSure, an FDA approved laser treatment for body contouring), hair removal, skin revitalisation and ... Combined the five products cover eight

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Cara Therapeutics has a chronic pain treatment based on a peptide that is rendered orally bioavailable using Enteris Biopharma's Peptelligence platform, which combines a permeation enhancer and a calcium chelator ... As the intestines don't have sharp

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Aromatherapy Market : Quantitative Market Analysis, Current and Future Trends, 2016-2026

    Increasing preference for aromatherapy will also be instrumented by its efficiency in boosting cognitive performance, increasing blood circulation, strengthening immunity, improving digestion and reducing pain. ... Demand for aromatherapy is also


    Doctors’ goals, on the other hand, seem to be lower. “Keep doing what you are doing”, they tell Jan when she complains about her pain, continuing to prescribe the same treatment. ... work to shift beliefs and increase motivation to improve care and

  • Virtual reality—a change for the better in medical education

    VR’s usefulness in cancer treatment doesn’t just extend into pain management. ... The impact of virtual reality distraction on pain and anxiety during dental treatment in 4–6 year-old children: a randomized controlled clinical trial.

  • 6 things that doctors want

    Doctors want a stronger collaboration with industry with the objective of raising the quality of patient care and improving treatment outcomes.What this means is that the barriers to healthcare professional ... adherence conditions like hypertension–

  • Research Partnership

    Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America. ... Barriers to Biologic Treatment - Is Injecting Such a Pain?.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch